Liabooks Home|PRISM News

#Ozempic

Total 6 articles

A Hollywood red carpet background with a gold trophy and a digital scale.
ViralEN
Hollywood Celebrity Weight Loss 2026: 300lbs Shed and the GLP-1 Era

Explore the massive transformations of 30 celebrities in 2026. From Jelly Roll's 300lb loss to the ongoing debate over GLP-1 medications, discover how stars are reshaping their lives.

·
MC
Minho Choi
Kelly Osbourne in a reflective moment following health concerns
ViralEN
Kelly Osbourne Weight Loss 2026: Viral Clip Sparks Intense Health Debate

Kelly Osbourne weight loss 2026 controversy reaches a boiling point after a new viral video. Learn about her response and the impact of Ozzy Osbourne's passing.

·
MC
Minho Choi
Ozempic bottle with global shipping routes between India and USA
EconomyEN
Canadian Pharmacy Platform to Facilitate India-Sourced Ozempic Sales for US Patients

A Canadian pharmacy platform is now offering India-sourced Ozempic to US patients, aiming to bypass high domestic costs and supply shortages. Explore the impact on the pharma market.

·
SP
Seoyeon Park
PRISM

PRISM by Liabooks

PRISM
Advertise with Us

Place your ad in this space

[email protected]
Amanda Bynes walking confidently on a sunny street
ViralEN
Amanda Bynes Weight Loss 2025: From 180 to 152 lbs on GLP-1 Journey

Amanda Bynes shares her 28lb weight loss journey in 2025. From 180 to 152 lbs using Semaglutide (GLP-1), Bynes is embracing transparency and recovery.

·
MC
Minho Choi
The Ozempic Effect: How New Weight-Loss Drugs Are Forcing a $100B Overhaul of the Food Industry
EconomyEN
The Ozempic Effect: How New Weight-Loss Drugs Are Forcing a $100B Overhaul of the Food Industry

Discover how the approval of new weight-loss drugs is forcing food giants like Nestlé to overhaul their products. An analysis of the 'Ozempic effect' on consumer habits and the investment landscape.

·
SP
Seoyeon Park
The 'GLP-3' Illusion: How Social Media is Forging Pharma's Next Billion-Dollar Drugs
ViralEN
The 'GLP-3' Illusion: How Social Media is Forging Pharma's Next Billion-Dollar Drugs

Viral hype around 'GLP-3' isn't just misinformation. It's a signal that social media now pre-shapes demand for drugs still in clinical trials. A PRISM analysis.

·
MC
Minho Choi
PRISM

Advertise with Us

[email protected]